Sanofi Dengue Bid Seen as $2.6 Billion Hit or Major Flop – Bloomberg

Sanofi Dengue Bid Seen as $2.6 Billion Hit or Major Flop
Bloomberg
strain in Thailand at the time of the trial. Sanofi is now studying the shot among more than 30,000 children and adolescents in Latin America and Southeast Asia. The company offered to fly reporters from Asia and South America in business class

and more »